Snapshot · The Diary Of A CEO with Steven Bartlett
The average human body contains approximately 5,000 trillion mitochondria — roughly 1,000 per cell — making them the primary engine of all biological energy.
Where this was said
At 9:19 · chapter starts 3:28
Steven Bartlett asks Dr. Picard what he knows that most people don't — and the answer is deceptively simple: we are energy, not bodies that happen to have energy. Picard grounds this in hard science, describing how mitochondria rip electrons from food, flow them toward oxygen like a tiny electrical circuit, and release heat as a byproduct — which is literally why shaking someone's hand feels warm. He then introduces the three principles that govern everything: (1) you are the energy flowing through the body; (2) there is a fixed, finite energy budget that cannot be expanded simply by eating more; and (3) life requires resistance — without something to push against, energy cannot transform. The origin story of mitochondria as ancient bacteria that merged with a host cell 1.5 billion years ago is woven in to explain why they are also a distributed intracellular communication system, not merely an energy factory. By the end of this chapter, the listener understands that mitochondria are both the source and the bottleneck of everything they feel.
The body has a fixed energy budget, and overloading it with food — especially sugar — doesn't produce more energy, it creates resistance and heat. The solution isn't eating more; it's becoming more efficient by reducing waste from stress, toxins, and mitochondrial overload.
Animals first sensed light 540 million years ago, triggering an evolutionary acceleration known as the Cambrian explosion within 10 million years.
It is estimated that half of all cortical activity in the human brain is involved in visual function, underscoring vision's central role in intelligence.
Cognitive neuroscience literature shows that by age 6, humans can recognize tens of thousands of different object categories — far more data than early AI systems were trained on.
Only about 3% of FDA-approved drugs have genuinely unclear mechanisms of action, making an unknown mechanism a meaningful early red flag for any compound.
Even compounds that clear preclinical testing often fail in humans: 30 to 50% of drugs entering phase 1 trials do not advance to phase 2, frequently because human behavior differs from animal models.
More than 80% of published BPC-157 research comes from a single academic group whose researchers have IP and commercial interests connected to the molecule, limiting independent replication.
Roughly 100 peptide drugs are already FDA-approved, about 150 more are in clinical trials, and 600–700 are in preclinical development, underscoring the legitimacy of peptide science broadly.
The scientist who discovered BPC-157 refused to disclose the screening method used to identify the compound and has never fully published the parent protein sequence — what Peter Attia calls 'scientific trust me, bro.'
The brain's visual, auditory, and motor cortices light up nearly identically whether an experience is real or imagined, making visualization a form of actual neural training.
We use essential and analytics cookies to run Vuci. To understand how the site is used: Privacy Policy.
Install Vuci on your phone
Add it to your home screen for a faster, app-like experience.
Install Vuci on your phone
Tap the Share button, then “Add to Home Screen”.
A new version is available
Reload to get the latest Vuci.